Automated Ultrasound-Based, Super Intelligence (SI)-Enabled Fracture Detection

What the buyer is asking for

The Center for Biomedical Advanced Research and Development Authority (BARDA) intends to use responses to this Sources Sought Notice (SSN) for planning purposes. BARDA will not award any contracts under this Notice, but rather seeks current and forecasted prices, inventories, capabilities, and other pertinent marketplace data. This Notice is issued by the Center for Biomedical Advanced Research and Development Authority (BARDA) to identify innovative medical countermeasure technologies to enable rapid triage of musculoskeletal injuries such as fractures and soft tissue injuries of extremities. This request is for information only and is intended to assess the current state of commercially available technologies and technologies nearing commercial availability that support automated ultrasound-based fracture detection using technologies commonly known as Artificial Intelligence (AI). Consistent with Executive Order 14434, “Inaugurating the Era of Super Intelligence,” AI- technologies are now referred to as Super Intelligence (SI) throughout this notice, including in the title and should be referred the same in the response. The Center for Biomedical Advanced Research and Development Authority (BARDA) intends to use responses to this Sources Sought Notice (SSN) to inform planning for the potential acquisition of ultrasound-based devices capable of capturing and displaying anatomical data. Potential acquisition and inventory approaches include device purchases or leases supported by vendor-managed inventory (VMI) arrangements. BARDA seeks information on technologies that could assist clinical care providers in visualizing or detecting musculoskeletal injuries, including fractures and soft tissue injuries, to support triage and initial treatment in emergency departments, urgent care centers, and field settings. These devices could also support continued evaluation and treatment in definitive orthopedic care settings, consistent with applicable regulatory authorizations and intended uses. The U.S. Department of Health and Human Services (HHS) leads Federal public health and medical preparedness and response efforts, including supporting the research, development, acquisition, and availability of medical countermeasures (MCMs). These efforts address the health consequences of chemical, biological, radiological, and nuclear (CBRN) threats, pandemic influenza, and emerging infectious diseases, including threats arising from deliberate, accidental, or naturally occurring events. This SSN supports planning for medical capabilities that could strengthen the Nation’s preparedness for and response to emergencies involving traumatic injuries. The Project BioShield Act of 2004 (Pub. L. No. 108-276) established authorities for procuring qualifying security countermeasures for the Strategic National Stockpile (SNS). The Pandemic and All-Hazards Preparedness Act of 2006 (Pub. L. No. 109-417) further strengthened the Nation’s medical countermeasure development and preparedness framework. The National Health Security Strategy 2023–2026 provides additional strategic context for strengthening preparedness, response, and recovery capabilities. Consistent with these preparedness objectives, this Sources Sought Notice seeks information on potential approaches to improve the availability and accessibility of relevant medical devices across health care settings. Approaches of interest include purchase, lease, vendor-managed inventory (VMI), and arrangements that combine access to devices with maintenance and readiness support. Information received will inform acquisition planning and assessment of these approaches, subject to applicable statutory authorities, acquisition requirements, and availability of funds. These documents represent the foundation for addressing the Nation’s CBRN MCM needs. Amongst the foundational documents referenced above, musculoskeletal injuries such as fractures resulting from nuclear blast explosions and structural collapse,…

How this compares

• This is one of 88 open tenders in United States for Medical equipments, pharmaceuticals and personal care products.
• Bidders were given 29 days from publication to the deadline; the median for open tenders in United States is 23 days.

More open tenders from this buyer

Similar open tenders